Truveta news For media inquiries, please email news@truveta.com A year later: New GLP-1 clinical trial results validate Truveta’s real-world data study December 6, 2024 Truveta achieves HITRUST r2 Certification November 20, 2024 Truveta Data now includes more than 120 million de-identified patients November 14, 2024 Truveta Tru, a research assistant powered by generative AI, now in Truveta Studio October 28, 2024 Truveta recognized on national and Seattle LinkedIn Top Startup 2024 lists October 9, 2024 Truveta and the University of Washington’s CHOICE Institute partner to advance health economics and outcomes research September 4, 2024 Ensuring privacy and compliance of AI August 30, 2024 Truveta moves up on GeekWire’s Top 200 startup list August 19, 2024 « Previous 1 … 5 6 7 … 13 Next » Truveta in the news Children who miss early vaccines more likely to not get the MMR shot by age 2 Women with PCOS seek relief in weight-loss drugs Weight Loss Drugs Now Account For 1 In 14 Prescriptions, Study Says FDA to streamline approvals for generic biological drugs in latest move targeting health costs See all articles Recent press releases Truveta CEO Terry Myerson announces retirement Rapid response to heat waves: Using electronic health records to protect patients in near-real time Johns Hopkins-led study supported by Truveta Data earns NIH R01 grant for GLP-1 research Truveta outlines a path toward a continuously learning healthcare system in new peer-reviewed publication See all press releases Images Truveta logo Format: PNG Truveta Data Map Format: PNG Truveta Health System Members Format: PNG
A year later: New GLP-1 clinical trial results validate Truveta’s real-world data study December 6, 2024
Truveta and the University of Washington’s CHOICE Institute partner to advance health economics and outcomes research September 4, 2024